Chris Mirabile, Founder & CEO of NOVOS Labs, discusses the nine hallmarks of aging and his personal journey towards exceptional biological age. Topics include balancing short-term health vs. longevity, electrolyte drinks, gut health, and combatting cellular senescence with natural compounds.

Chris Mirabile, founder and CEO of Novos Labs, dives into the science of aging and groundbreaking strategies to reduce biological age. He shares his personal journey and explores innovative supplements like fisetin and glycine, explaining their roles in longevity. The conversation highlights the significance of ingredient selection and the clinical trials supporting Novos’ products. Chris also reveals his daily health regimen and discusses the importance of personalized nutrition for optimizing health. Discover how to take control of your aging process!

In this episode, Chris Mirabile shares his journey to slow down his biological age and improve longevity. Topics include targeting hallmarks of aging, the Novos Core supplement, rejuvenation Olympics, longevity tests, and Chris' longevity routine. Learn how he's defying age and optimizing health in his 40s.

Chris Mirabile, Founder & CEO of NOVOS, shares secrets for reversing aging, aging 37% slower biologically than chronologically. Discussions include stress management, debunking longevity myths, importance of sleep, training, and diet. The podcast also covers aspects of business, mindset, and passion.

Brain tumor survivor turned health and wellness advocate, Chris Mirabile, shares his journey and emphasizes the need for considering both short-term and long-term effects of lifestyle choices. He discusses potential risks associated with prescription drugs. The podcast delves into the science of aging, exploring biological age, epigenetic methylation clocks, and telomere length. The episode highlights the importance of individualized nutrition and the connection between longevity and chronic diseases. It also covers the structure and motivations behind No Votes, a public benefit corporation.